NASDAQ: CASI
Casi Pharmaceuticals Inc Stock Ownership - Who owns Casi Pharmaceuticals?

Insider buying vs selling

Have Casi Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CASI insiders and whales buy or sell their stock.

CASI Shareholders

What type of owners hold Casi Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Celgene Corp153.30%23,750,000$57.71MInsider
Dapeng Li76.63%11,872,026$28.85MInsider
Sparkle Byte Ltd65.83%10,198,518$24.78MInsider
Spectrum Pharmaceuticals Inc64.85%10,047,675$24.42MInsider
Idgaccel China Growth Fund III LP63.08%9,773,370$23.75MInsider
Wealth Strategy Holding Ltd58.66%9,087,888$22.08MInsider
Weiwu He16.53%2,560,265$6.22MInsider
Vr Adviser LLC6.37%987,259$2.40MInstitution
James Huang5.09%788,374$1.92MInsider
Foresite Capital Management VI LLC5.08%787,121$1.91MInstitution

1 of 3

CASI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CASI2.75%97.25%
IGC3.35%22.33%Net Buying
MURA47.53%3.28%Net SellingNet Selling
MEIP15.02%84.98%
RADX0.02%0.00%

Casi Pharmaceuticals Stock Ownership FAQ

Who owns Casi Pharmaceuticals?

Casi Pharmaceuticals (NASDAQ: CASI) is owned by 14.49% institutional shareholders, 513.20% Casi Pharmaceuticals insiders, and 0.00% retail investors. Celgene Corp is the largest individual Casi Pharmaceuticals shareholder, owning 23.75M shares representing 153.30% of the company. Celgene Corp's Casi Pharmaceuticals shares are currently valued at $54.39M.

If you're new to stock investing, here's how to buy Casi Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.